Virtus LifeSci Biotech Products ETF

Virtus LifeSci Biotech Products ETF
  • Pininvest Analysis

About - Virtus Investment Partners VRTS/NASDAQ is a premier provider of investment solutions to individuals, financial advisors, and institutions. We aim to offer distinguished strategies and original perspectives to help our clients achieve better outcomes

Virtus ETF Solutions is an industry leader in subadvised exchange traded funds

Virtus LifeSci Biotech Products ETF  BBP/NYSEARCA invests in products stage companies, which are typically more established companies with much clinical trial failure risk behind them. They have already successfully completed multiple human clinical trials and have received FDA approval to sell and market a drug

LifeSci Index Partners, LLC is a New York-based index provider of healthcare-based stock market indices. The LifeSci team is comprised of investment professionals with experience in biotechnology equity research, in organic chemistry research in academia, and at pharmaceutical and biotechnology companies

Note from DATAvariance
The complete list of the 38 BBP constituents on the theme are not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

For actual performance of the fund, which maybe higher or lower, depending on the weighting and trades decided by the provider, please check the information available on the Virtus LifeSci Biotech Products ETF site or contact your advisor

More about Virtus LifeSci Biotech Products ETF

Virtus LifeSci Biotech Products ETF • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Vol. Contrib. MDD
 
ACADIA Pharmaceuticals Inc ACAD NASDAQ Health Care Drug Manufacturers - Diversified USD 27.10 3.9 B 10.3% 77%   4% -47%
Acorda Therapeutics Inc ACOR NASDAQ Health Care Biopharmaceuticals USD 14.39 685 M -41.4% 62%   1% -60%
Alexion Pharmaceuticals Inc. ALXN NASDAQ Health Care Biopharmaceuticals USD 133.51 30 B 9.4% 36%   3% -32%
Amgen Inc. AMGN NASDAQ Health Care Biopharmaceuticals USD 191.31 119 B 6.3% 23%   1% -15%
Biogen Inc BIIB NASDAQ Health Care Biopharmaceuticals USD 325.65 64 B 17.0% 34%   2% -27%
BioMarin Pharmaceutical BMRN NASDAQ Health Care Biopharmaceuticals USD 93.36 17 B 11.4% 34%   2% -24%
Celgene CELG NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 87.99 62 B -0.6% 35%   2% -37%
Clovis Oncology, Inc. CLVS NASDAQ Health Care Biopharmaceuticals USD 27.48 1.5 B -51.6% 77%   1% -81%
Dynavax Technologies DVAX NASDAQ Health Care Biopharmaceuticals USD 7.78 498 M -53.4% 60%   1% -63%
Enanta Pharmaceuticals Inc ENTA NASDAQ Health Care Biopharmaceuticals USD 102.57 2.0 B 18.5% 52%   3% -48%
Exelixis EXEL NASDAQ Health Care Biopharmaceuticals USD 24.14 7.2 B 1.4% 52%   3% -44%
Gilead Sciences Inc. GILD NASDAQ Health Care Biopharmaceuticals USD 65.02 83 B -13.5% 26%   1% -23%
Halozyme Therapeutics HALO NASDAQ Health Care Biopharmaceuticals USD 16.52 2.4 B -20.7% 41%   2% -37%
Incyte Corporation INCY NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 85.62 18 B -0.8% 44%   2% -34%
Intercept Pharmaceuticals ICPT NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 113.56 3.4 B 79.2% 58%   6% -33%
Ionis Pharmaceuticals IONS NASDAQ Health Care Biopharmaceuticals USD 79.52 11 B 51.1% 50%   4% -23%
Ironwood Pharmaceuticals IRWD NASDAQ Health Care Drug Manufacturers - Diversified USD 13.40 2.1 B -11.1% 54%   2% -56%
Keryx Biopharmaceuticals KERX NASDAQ Health Care Kidney Failure USD 3.36 344 M -22.6% 53%   2% -56%
Lexicon Pharmaceuticals LXRX NASDAQ Health Care Diabetes USD 7.62 810 M -10.4% 65%   3% -68%
Ligand Pharmaceuticals Inc LGND NASDAQ Health Care Clinical trial work USD 124.63 2.5 B -26.0% 47%   2% -61%
Medicines Co MDCO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 27.14 2.0 B -16.2% 45%   2% -58%
Momenta Pharmaceuticals Inc MNTA NASDAQ Health Care Biopharmaceuticals USD 14.53 1.4 B -20.4% 61%   2% -67%
Nektar Therapeutics NKTR NASDAQ Health Care Clinical trial work USD 34.93 6.1 B -66.7% 80%   1% -72%
Neurocrine Biosciences NBIX NASDAQ Health Care Biopharmaceuticals USD 84.81 7.7 B -0.4% 45%   2% -46%
Omeros Corp OMER NASDAQ Health Care Biopharmaceuticals USD 16.70 818 M 52.4% 100%   6% -60%
Portola Pharmaceuticals PTLA NASDAQ Health Care Biopharmaceuticals USD 33.05 2.2 B -1.1% 65%   3% -65%
Puma Biotechnology PBYI NASDAQ Health Care Biopharmaceuticals USD 42.37 1.6 B -41.8% 95%   2% -72%
Radius Health RDUS NASDAQ Health Care Biopharmaceuticals USD 18.80 860 M -46.6% 55%   2% -64%
Regeneron Pharmaceuticals Inc. REGN NASDAQ Health Care Biopharmaceuticals USD 407.60 45 B 20.2% 31%   2% -18%
Retrophin, Inc. RTRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 23.96 992 M -2.3% 46%   3% -38%
Sarepta Therapeutics, Inc. SRPT NASDAQ Health Care Biopharmaceuticals USD 126.82 9.0 B 61.0% 62%   5% -40%
Seattle Genetics Inc. SGEN NASDAQ Health Care Biopharmaceuticals USD 73.45 12 B 31.8% 42%   3% -37%
Spark Therapeutics ONCE NASDAQ Health Care Biopharmaceuticals USD 113.96 4.3 B 82.6% 100%   8% -62%
TESARO TSRO NASDAQ Health Care Biopharmaceuticals USD 74.96 4.1 B 22.1% 86%   4% -60%
Theravance Biopharma, Inc. TBPH NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 24.08 1.3 B -9.5% 45%   2% -36%
United Therapeutics Corporation UTHR NASDAQ Health Care Biopharmaceuticals USD 118.85 5.2 B 8.0% 33%   2% -22%
Vanda Pharmaceuticals Inc. VNDA NASDAQ Health Care Drug Manufacturers - Diversified USD 18.22 959 M 6.9% 55%   2% -43%
Vertex Pharmaceuticals VRTX NASDAQ Health Care Biopharmaceuticals USD 187.48 48 B 9.8% 32%   2% -21%